127 related articles for article (PubMed ID: 36379678)
21. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
22. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
Gangopadhyay A; Saha A
J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
[TBL] [Abstract][Full Text] [Related]
23. A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer.
Qayoom H; Alkhanani M; Almilaibary A; Alsagaby SA; Mir MA
Med Oncol; 2023 Jun; 40(7):202. PubMed ID: 37308611
[TBL] [Abstract][Full Text] [Related]
24.
Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
[TBL] [Abstract][Full Text] [Related]
25. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.
Hakami MA; Hazazi A; Albloui F; Gharib AF; Alsaeedi FA; Abdulaziz O; Alhazmi AY; Alsaiari AA
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203761
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
27. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
28. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
29. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
[No Abstract] [Full Text] [Related]
31. Integrating network pharmacology with molecular docking for elucidation of molecular biological mechanisms of Jiedu Qingjin formula for non-small cell lung cancer.
Xu B; Dan W; Wu J; Wang X; Qin X; Han Y; Song X; Zhang X; Li J
J Biomol Struct Dyn; 2023 Sep; ():1-20. PubMed ID: 37771185
[TBL] [Abstract][Full Text] [Related]
32.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
33. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics.
Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA
J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
Joshi T; Joshi T; Sharma P; Chandra S; Pande V
J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
[No Abstract] [Full Text] [Related]
35. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
36. Multitargeted molecular docking and dynamics simulation studies of flavonoids and volatile components from the peel of
Rajiv Gandhi G; Sharanya CS; Jayanandan A; Haridas M; Edwin Hillary V; Rajiv Gandhi S; Sridharan G; Sivasubramanian R; Silva Vasconcelos AB; Montalvão MM; Antony Ceasar S; Sousa NF; Scotti L; Scotti MT; Gurgel RQ; Quintans-Júnior LJ
J Biomol Struct Dyn; 2024 Apr; 42(6):3051-3080. PubMed ID: 37203996
[No Abstract] [Full Text] [Related]
37.
Teli MK; Kumar S; Yadav DK; Kim MH
J Biomol Struct Dyn; 2021 Feb; 39(2):703-717. PubMed ID: 31914862
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
39. Discovery of phyto-compounds as novel inhibitors against
Kar B; Kundu CN; Pati S; Bhattacharya D
J Biomol Struct Dyn; 2023 Mar; 41(4):1267-1280. PubMed ID: 34961397
[TBL] [Abstract][Full Text] [Related]
40. Identification of common genes in obesity and cancer through network interaction and targeting those genes by virtual screening approach.
Modanwal S; Mishra N
J Biomol Struct Dyn; 2023 Feb; 41(3):1109-1127. PubMed ID: 34961392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
